Horiba shares dropped 3.9% after the company released its fourth-quarter operating profit results and fiscal year guidance.

Horiba Ltd. (6856.TO) Japan Year Ended December 31 GROUP 2025 2024 Revenue Y333.08 bln Y317.37 bln Operating Profit Y53.04 bln Y48.34 bln Pretax Profit Y54.23 bln Y50.17 bln Net Profit Y37.09 bln ...

HORIBA (TSE:6856) is attracting attention as investors size up its performance in the evolving technology and measurement solutions landscape. While the market takes stock, recent momentum hints at ...

The 2026 edition of the event saw HORIBA showcasing a comprehensive portfolio of technologies spanning Haematology, ...

HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help hematology laboratories simplify and expedite the performance of blood ...

Horiba is likely undervalued due to it being under followed, and offers a rare combination of a quality business at an attractive price. The company has high market share in specialized devices in ...

Horiba shares have declined due to a stronger Yen and market dislocation, but the market likely overreacted. Horiba's diversified segments and strong R&D investments position it well for future growth ...

An announcement from Horiba ( (JP:6856)) is now available. HORIBA, Ltd. reported a 6.7% increase in net sales and a 21% rise in net income attributable to shareholders for the nine months ending ...

As experts in hematology HORIBA UK Ltd, Medical announces that the Company has published a white paper entitled, ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Prominent absorbed brands include Jobin Yvon, Glen Spectra, IBH, SPEX, Instruments S.A, ISA, Dilor, Sofie, SLM, and Beta Scientific. By combining the strengths of the ...

HORIBA (TSE:6856) has attracted fresh attention after a strong past 3 months share move, prompting investors to revisit how its current valuation lines up with recent business performance and longer ...